Defence Therapeutics(TSE:DTC)
CA$0.31-0.03 (-7.46%)
TSE:DTC
Defence Therapeutics financials statements
CA$0.31
At close:-0.03 (-7.46%)
Want to see TSE:DTC full AI Analyst Report?
Defence Therapeutics (DTC) Income Statement
14 Followers
Defence Therapeutics Income Statement
Last quarter (Q4 2026), Defence Therapeutics's total revenue was C$0.00. In Q4, Defence Therapeutics's net income was C$-1.50M. See Defence Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Sep 25 | Jun 24 | Sep 23 | Sep 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ -72.11K | C$ -72.34K | C$ -90.92K | C$ -13.82K | C$ 0.00 | |
| C$ 4.92M | C$ 3.20M | C$ 12.66M | C$ 6.48M | C$ 3.56M | |
| Depreciation and Amortization | C$ 72.11K | C$ 72.34K | C$ 90.92K | C$ 13.82K | C$ 7.27M |
| C$ -4.92M | C$ -3.13M | C$ -12.66M | C$ -6.48M | C$ 0.00 | |
| C$ -4.99M | C$ -3.27M | C$ -12.66M | C$ -6.55M | C$ -3.56M | |
| C$ -1.79M | C$ -253.20K | C$ -537.24K | C$ -322.42K | C$ -3.78M | |
| C$ -6.78M | C$ -3.52M | C$ -13.19M | C$ -6.87M | C$ -7.34M | |
| C$ -6.70M | C$ -3.52M | C$ -13.19M | C$ -6.76M | C$ -7.34M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.11 | C$ -0.07 | C$ -0.30 | C$ -0.17 | C$ -0.20 |
| Diluted EPS | C$ -0.11 | C$ -0.07 | C$ -0.30 | C$ -0.17 | C$ -0.20 |
| Weighted Average Shares Outstanding | 62.18M | 49.83M | 44.63M | 39.66M | 36.08M |
| Weighted Average Shares Outstanding (Diluted) | 62.18M | 49.83M | 44.63M | 39.66M | 36.08M |
Currency in CAD
